PROVIDER PROFILE · NPI 1023108669

John CloreM.D.

EndocrinologyLynchburg, VAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

459

Unique beneficiaries

—

Total services

759

Distinct HCPCS

Medicare payment

$42K

Peer benchmark

Total Medicare services vs. 165 Endocrinology providers in VA — below median (cohort median 1,021).

PRESCRIBING · PART D · 2024

Total Rx claims

3,128

Beneficiaries

—

Total drug cost

$1.2M

Distinct drugs

Brand share

71.7%

Top prescribed drugs

Semaglutide280 claims

Insulin Glargine,hum.Rec.Anlog263 claims

Metformin Hcl225 claims

Metformin Hcl173 claims

Pen Needle, Diabetic144 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$210

Payment records

By payment type

Food and Beverage$210

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 490059

Hospital

CCN 490069

Hospital

CCN 490136

Hospital

REFERRAL NETWORK

Where John Clore's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY	53	203

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY	64	278
CENTRA HEALTH INC	26	76
Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC	22	49

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history